Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection | Zendy

Marcelo Wolff | Zendy; Mónica L. Acevedo | Zendy; María Antonieta Núñez | Zendy; Mónica Lafourcade | Zendy; Aracelly Gaete-Argel | Zendy; Ricardo SotoRifo | Zendy; Fernando ValienteEcheverría | Zendy

Open Access

Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection

Author(s) -

Marcelo Wolff,

Mónica L. Acevedo,

María Antonieta Núñez,

Mónica Lafourcade,

Aracelly Gaete-Argel,

Ricardo SotoRifo,

Fernando ValienteEcheverría

Publication year - 2022

Publication title -

journal of travel medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.985

H-Index - 59

eISSN - 1708-8305

pISSN - 1195-1982

DOI - 10.1093/jtm/taac010

Subject(s) - medicine , titer , covid-19 , neutralizing antibody , virology , antibody response , antibody , antibody titer , immunology , health care , disease , infectious disease (medical specialty) , outbreak , economics , economic growth

We report neutralizing antibody titers (NAbTs) elicited by CoronaVac and BNT162b2 vaccines in healthcare workers with and without prior SARS-CoV-2 infection using both a pseudotype-based assay and a commercial kit. NAbTs were higher for the mRNA vaccine and increased in all previously infected. Good correlation between both assays was found.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research